A B52 injection combines three medications into a single intramuscular (IM) syringe: diphenhydramine (Benadryl) 25 mg, haloperidol (Haldol) 5 mg, and lorazepam (Ativan) 2 mg. The nickname comes from the first letters and numbers of each component. All three drugs are physically compatible in the same syringe, which means a properly prepared B52 can be drawn up and administered as one injection rather than three, but the process requires attention to volumes, draw order, and a quick visual check before it goes into the patient.
The Three Components and Their Standard Doses
The classic B52 uses fixed doses that have become something of an institutional default in emergency departments and psychiatric facilities across North America. The standard recipe is diphenhydramine 25 mg, haloperidol 5 mg, and lorazepam 2 mg, all given together as a deep intramuscular injection, typically into the deltoid or the ventrogluteal site.1PubMed Central. Ketamine Versus Haloperidol/Lorazepam/Diphenhydramine Combination Treatment for Management of Acute Agitation in the Emergency Department Some facilities use diphenhydramine 50 mg instead of 25 mg, so always verify the dose your institution has protocolized before drawing anything up.
In terms of volume, the math is straightforward when you use the most common concentrations stocked in hospitals. Haloperidol typically comes as 5 mg/mL, so you need 1 mL. Lorazepam usually comes as 2 mg/mL, which is another 1 mL. Diphenhydramine is commonly stocked as 50 mg/mL, meaning 25 mg equals 0.5 mL. The total for a standard B52 works out to about 2.5 mL, a comfortable volume for a single IM injection. If your facility uses the 50 mg diphenhydramine dose, the total rises to 3 mL, still within the range most IM sites can handle.
Drawing It Up Step by Step
The entire point of using a single syringe is speed and reduced pain for the patient. In an acute agitation scenario, you often do not have the luxury of preparing three separate injections and finding three separate sites. Combining them into one syringe is the standard approach, and research on physical compatibility supports it.
Use a syringe large enough for the total volume, typically a 3 mL syringe with an appropriate IM needle (usually 21-gauge, 1 to 1.5 inches depending on the patient’s body habitus and the injection site). There is no universally mandated draw order, but a common and practical sequence runs like this:
- Haloperidol first: Draw up 1 mL (5 mg) from the haloperidol vial. Haloperidol is a clear, colorless solution that serves as a useful visual baseline.
- Diphenhydramine second: Draw up 0.5 mL (25 mg) into the same syringe. Diphenhydramine is also a clear solution and mixes easily with haloperidol.
- Lorazepam last: Draw up 1 mL (2 mg). Lorazepam is the most chemically finicky of the three, so adding it last minimizes the time it sits in a mixed solution before injection.
After drawing up all three, gently roll or swirl the syringe to mix. Do not shake it vigorously. Then perform a visual inspection, which is the single most important quality check before you give the injection.
Why These Three Are Safe to Combine in One Syringe
Not all injectable medications can share a syringe. Mixing incompatible drugs can produce precipitation, which means tiny solid particles form in the solution. Injecting a precipitated solution into muscle tissue is at best ineffective and at worst dangerous. The good news is that the triple combination of lorazepam, haloperidol, and diphenhydramine has been specifically tested and found to be physically compatible.2PubMed Central. Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions Researchers used both visual inspection and particle counters to confirm that the combination does not form precipitates when drawn into the same syringe.
That said, compatibility depends on the concentrations and formulations your pharmacy stocks. Generic formulations occasionally use different preservatives or vehicles that can affect stability. If your facility recently switched suppliers for any of these three medications, it is worth confirming with pharmacy that the new product has been verified as compatible in combination.
Visual Inspection Before You Inject
Once the three drugs are combined in the syringe, hold it up to a light source and look at the solution from different angles. You are looking for cloudiness, discoloration, or visible particles. A properly mixed B52 should appear as a clear to very slightly yellow solution with no floating specks. If you see anything unusual, do not administer it. Discard the syringe and prepare a fresh one.
In hospital pharmacy research, visual inspection for microprecipitates is sometimes done using a focused light beam against a dark background, which can catch particles too small to see under normal room lighting.3International Journal of Pharmaceutical Compounding. Study of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam You are unlikely to have this setup at the bedside in an emergency, but the principle matters: look carefully, because some precipitates are subtle. If the light in your area is dim, move to a brighter spot or use a penlight to transilluminate the syringe before injecting.
What Each Drug Brings to the Mix
The three components are not redundant. Each targets a different receptor system, and the idea behind the combination is that together they produce rapid, reliable sedation while theoretically reducing the dose needed of any single agent.
Haloperidol is an antipsychotic. It blocks dopamine receptors in the brain and is the primary antipsychotic component of the cocktail. At 5 mg IM, it typically begins working within 15 to 30 minutes and provides the longest-lasting effect of the three drugs. It is the workhorse of the combination.
Lorazepam is a benzodiazepine. It enhances the calming neurotransmitter GABA and provides rapid anxiolysis and sedation. It works faster than haloperidol and helps bridge the gap until haloperidol reaches its peak. It also provides anticonvulsant activity, which matters in patients who may be withdrawing from alcohol or other substances.
Diphenhydramine is an antihistamine with sedating properties. Its inclusion in the B52 serves two theoretical purposes: adding an additional sedative layer and preventing extrapyramidal side effects (involuntary muscle movements, stiffness, or restlessness) that haloperidol can cause. That second rationale is the one clinicians have debated most in recent years.
Does the Diphenhydramine Actually Earn Its Spot?
This is where the evidence gets genuinely interesting, and where a lot of practitioners are reconsidering a long-standing habit. The “B” in B52 was included partly on the assumption that prophylactic diphenhydramine would prevent the uncomfortable and sometimes frightening muscle side effects that haloperidol can trigger. But when researchers tested that assumption rigorously, the picture was muddier than expected.
A systematic review and meta-analysis pooling data from seven studies found that adding diphenhydramine did not clearly reduce the overall rate of extrapyramidal symptoms or akathisia (an agonizing inner restlessness). However, when the analysis was limited to placebo-controlled studies specifically, diphenhydramine did show a meaningful reduction in extrapyramidal effects.4PubMed. Prophylactic Administration of Diphenhydramine to Reduce Neuroleptic Side Effects in the Acute Care Setting: A Systematic Review and Meta-Analysis So the answer is not a clean yes or no. The benefit depends on which studies you lean on and how you define the comparison.
A large multicenter retrospective study directly compared the full B52 (all three drugs) against just the “52” (haloperidol and lorazepam without diphenhydramine). Patients who got only the two-drug combination were more likely to need an anti-muscle-spasm medication within two days, which suggests diphenhydramine was doing something protective. But those same patients had shorter emergency department stays, lower rates of blood pressure drops, and fewer episodes of oxygen desaturation than the B52 group.5PubMed. Efficacy of Combination Haloperidol, Lorazepam, and Diphenhydramine vs. Combination Haloperidol and Lorazepam in the Treatment of Acute Agitation: A Multicenter Retrospective Cohort Study The B52 group also ended up in physical restraints more often, though that finding could reflect differences in the patient populations rather than a direct drug effect.
The takeaway for clinicians drawing up a B52 is that the combination works and is entrenched in practice, but the diphenhydramine component is not as clearly beneficial as was once assumed. Some emergency physicians have shifted toward the two-drug “52” as their default and reserve the full B52 for cases where they are especially worried about haloperidol-related movement side effects. This is a conversation worth having with your medical director if your protocol still mandates the triple combination for every agitated patient.
Safety Monitoring After Administration
Drawing up the injection correctly is only half the job. What happens in the 30 to 60 minutes after you give it matters just as much. All three drugs in a B52 can lower blood pressure, and their effects are additive. The same multicenter study that compared B52 to the two-drug version found that the full triple combination was associated with notably more hypotension and more cases where oxygen levels dropped.5PubMed. Efficacy of Combination Haloperidol, Lorazepam, and Diphenhydramine vs. Combination Haloperidol and Lorazepam in the Treatment of Acute Agitation: A Multicenter Retrospective Cohort Study
At minimum, after giving a B52, you should plan for the following monitoring:
- Pulse oximetry: Continuous or frequent spot checks for at least 30 to 60 minutes. The sedating combination can depress respiratory drive, particularly in patients who are also intoxicated.
- Blood pressure: Check within 15 minutes and again at 30 to 60 minutes. The patient should ideally be positioned on their side or at least not supine and unmonitored.
- Mental status: The goal is calm, not comatose. If the patient is deeply unresponsive to stimulation, escalate your monitoring.
- Cardiac rhythm: Haloperidol has been associated with QT prolongation on electrocardiograms, though the risk with intramuscular dosing appears lower than with intravenous haloperidol.6Psychopharmacology Institute. Cardiac Side Effects of Psychiatric Medications Most reported cardiac events involved patients who had pre-existing heart conditions or were taking other medications that affect heart rhythm. Still, if cardiac monitoring is available and the patient has cardiac risk factors, using it is prudent.
Adjusting Doses for Higher-Risk Patients
The standard B52 doses were developed for otherwise healthy adults experiencing acute agitation. They are not appropriate for everyone. Research on risk factors for adverse events during chemical sedation has identified age over 65, alcohol intoxication, and receiving multiple sedating medications within a short window as independent predictors of complications.7PubMed Central. Which Emergent Medication Should I Give Next? Repeated Use of Emergent Medications to Treat Acute Agitation
For elderly patients, most institutional protocols recommend halving at least the haloperidol and lorazepam doses (for example, haloperidol 2.5 mg, lorazepam 0.5 to 1 mg). Diphenhydramine is particularly problematic in older adults because it crosses into the brain easily and can cause delirium, worsening the very agitation you are trying to treat. Many geriatric psychiatry guidelines recommend avoiding diphenhydramine in patients over 65 altogether, which effectively turns the B52 into a low-dose “52.”
Patients who are visibly intoxicated with alcohol or other central nervous system depressants are at heightened risk for respiratory depression when you add a benzodiazepine. In these cases, some clinicians reduce or omit the lorazepam component and rely primarily on haloperidol alone or haloperidol with diphenhydramine. The decision depends on what information you have about the patient’s substance use and how urgently you need the combination’s full sedating power.
Patients with known cardiac disease, a prolonged QT interval, or those already taking other drugs that affect heart rhythm deserve particular caution with the haloperidol component. While the cardiac risk of a single 5 mg IM dose in an otherwise healthy person is low, stacking risk factors makes the scenario less reassuring.
Repeat Dosing and What Comes Next
Sometimes one B52 is not enough. When a patient remains dangerously agitated after the first dose, the question of whether and how to redose requires careful thought. Evidence is sparse on the safety of repeated combination dosing, and some researchers have noted that the overall evidence base for using a first-generation antipsychotic, a benzodiazepine, and an anticholinergic together is thin to begin with.7PubMed Central. Which Emergent Medication Should I Give Next? Repeated Use of Emergent Medications to Treat Acute Agitation Stacking multiple sedating medications within a short time frame increases the chance of adverse events, so any repeat dose should come with renewed monitoring and a lower threshold for escalation.
If a full B52 has not calmed the patient within 30 to 45 minutes, many emergency physicians will reach for a different agent class entirely rather than repeating the same cocktail. Ketamine has gained traction in recent years as a second-line option for refractory agitation, and some departments now use it as a first-line alternative.1PubMed Central. Ketamine Versus Haloperidol/Lorazepam/Diphenhydramine Combination Treatment for Management of Acute Agitation in the Emergency Department The choice between repeating the B52 and switching to ketamine or another agent depends on your institution’s protocols and the clinical picture.
Common Preparation Mistakes to Avoid
The B52 is often drawn up under pressure, in chaotic situations, by staff who may not prepare it regularly. A few errors come up repeatedly in clinical practice:
- Wrong concentration of diphenhydramine: Diphenhydramine comes in both 50 mg/mL vials (for IM or IV use) and 10 mg/mL vials (diluted for IV push). Grabbing the wrong concentration changes your volume dramatically and could result in a significant overdose or underdose.
- Forgetting to check the lorazepam vial: Lorazepam for injection requires refrigeration. If a vial has been sitting at room temperature for an extended period, it may have degraded. Check the expiration date and storage conditions. A lorazepam solution that looks cloudy or discolored should be discarded.
- Drawing air into the syringe between drugs: Air bubbles between the layers of medication can make it harder to mix evenly and may cause an inaccurate delivered dose. Tap air out after each draw before pulling the next medication.
- Injecting too superficially: The B52 is an intramuscular injection, not subcutaneous. Use a needle long enough to reach muscle tissue, particularly in larger patients. Subcutaneous injection slows absorption unpredictably and increases the risk of local irritation or sterile abscess.
Labeling the syringe matters too. In the chaos of an agitation event, it is easy to set down a syringe and lose track of what is in it. Label it immediately after drawing it up, even if you plan to give it seconds later. Many medication errors in acute settings stem from unlabeled syringes that get confused with other prepared medications.
When Pre-Made Kits Simplify the Process
Some emergency departments and psychiatric facilities have moved toward pre-assembled B52 kits that contain the three vials, a syringe, an IM needle, an alcohol swab, and a printed instruction card in a single bag. These kits reduce the time spent hunting through a medication drawer during a crisis and minimize the chance of grabbing the wrong drug or concentration. If your facility does not stock pre-made kits, proposing them to your pharmacy committee is a low-cost, high-yield safety intervention. The kits do not change the pharmacology, but they remove several common failure points from the preparation process.
For facilities that use automated dispensing cabinets, programming a B52 combination as a linked order so that all three vials dispense together achieves a similar benefit without the physical kit. The goal in either case is the same: when the order comes in, every component should be immediately available and clearly identified, so the person drawing up the syringe can focus on preparation rather than scavenger hunting.